Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication. |
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy. |
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
3ZdfPPWyvbwBp1mZ
